Labcorp clinical trials

The registry lists 26 studies whose lead sponsor is Labcorp or one of 1 company grouped under it. 5 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 2, 2026.

Studies

Recruiting first, then most recently updated. Showing 26 of 26.

• Specimen Collection From Patients With Non-Hematologic Cancer for Use in Development of a Liquid Biopsy AssayRecruitingNCT02586389

  Sponsor listed in the registry: Sequenom, Inc. · First submitted before Sequenom, Inc. became part of Labcorp

• Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of ProclarixRecruitingNCT07543757

  Sponsor listed in the registry: Sequenom, Inc. · First submitted after Sequenom, Inc. became part of Labcorp

• Specimen Collection From Pregnant Women at Increased Risk for Fetal AneuploidyRecruitingNCT01429389

  Sponsor listed in the registry: Sequenom, Inc. · First submitted before Sequenom, Inc. became part of Labcorp

• Compliant Analysis of Patient Samples and DataEnrolling by invitationNCT04364503

  Sponsor listed in the registry: Sequenom, Inc. · First submitted after Sequenom, Inc. became part of Labcorp

• Non-Invasive Preeclampsia Screening and BiobankRecruitingNCT06643741

  Sponsor listed in the registry: Sequenom, Inc. · First submitted after Sequenom, Inc. became part of Labcorp

• Clinical Follow-up of Pregnant Subjects Undergoing NIPTCompletedNCT04595201

  Sponsor listed in the registry: Sequenom, Inc. · First submitted after Sequenom, Inc. became part of Labcorp

• The Effect of Guided Care With Vectra Compared to Treatment as Usual in Patients With Rheumatoid ArthritisCompletedNCT03631225

  Sponsor listed in the registry: Sequenom, Inc. · First submitted after Sequenom, Inc. became part of Labcorp

• Evaluation of the Labcorp COVID-19+Flu+RSV Test Home Collection KitCompletedNCT06008457

  Sponsor listed in the registry: Sequenom, Inc. · First submitted after Sequenom, Inc. became part of Labcorp

• Impact of Guided Care With the Vectra Multi-biomarker Disease Activity (MBDA) Blood TestCompletedNCT03810144

  Sponsor listed in the registry: Sequenom, Inc. · First submitted after Sequenom, Inc. became part of Labcorp

• Development of a NIPTT for Detecting Copy Number VariationsTerminatedNCT04774640

  Sponsor listed in the registry: Sequenom, Inc. · First submitted after Sequenom, Inc. became part of Labcorp

• Noninvasive Screening for Affected Pregnancies: Assay Development & Optimization in Affected PregnanciesCompletedNCT01052688

  Sponsor listed in the registry: Sequenom, Inc. · First submitted before Sequenom, Inc. became part of Labcorp

• Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk PregnanciesCompletedNCT01597063

  Sponsor listed in the registry: Sequenom, Inc. · First submitted before Sequenom, Inc. became part of Labcorp

• Clinical Evaluation of the SEQureDx T21 Test In High Risk PregnanciesCompletedNCT01555346

  Sponsor listed in the registry: Sequenom, Inc. · First submitted before Sequenom, Inc. became part of Labcorp

• Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMDCompletedNCT01880788

  Sponsor listed in the registry: Sequenom, Inc. · First submitted before Sequenom, Inc. became part of Labcorp

• Clinical Performance of the MaterniT21 PLUS LDT in Multiple Gestation PregnanciesTerminatedNCT02226315

  Sponsor listed in the registry: Sequenom, Inc. · First submitted before Sequenom, Inc. became part of Labcorp

• Association of Macular Pigment Optical Density (MPOD) and Genetic Variants in Complement Factor H in Subjects With Choroidal Neovascular (CNV)CompletedNCT01682382

  Sponsor listed in the registry: Sequenom, Inc. · First submitted before Sequenom, Inc. became part of Labcorp

• Genetic Load and Phenotype in Aggressive AMDCompletedNCT01650948

  Sponsor listed in the registry: Sequenom, Inc. · First submitted before Sequenom, Inc. became part of Labcorp

• Determination of Performance Characteristics of the MassPLEX Factor II/V Leiden TestCompletedNCT01835483

  Sponsor listed in the registry: Sequenom, Inc. · First submitted before Sequenom, Inc. became part of Labcorp

• Evaluation of the Association Between Genetic Load and Response to Anti-VEGF Therapy in AMD PatientsCompletedNCT01644513

  Sponsor listed in the registry: Sequenom, Inc. · First submitted before Sequenom, Inc. became part of Labcorp

• A Noninvasive Test for Fetal RHD GenotypeCompletedNCT00871195

  Sponsor listed in the registry: Sequenom, Inc. · First submitted before Sequenom, Inc. became part of Labcorp

• Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma MarkerCompletedNCT00971334

  Sponsor listed in the registry: Sequenom, Inc. · First submitted before Sequenom, Inc. became part of Labcorp

• Evaluation of a Noninvasive Fetal RHD Genotyping TestCompletedNCT01054716

  Sponsor listed in the registry: Sequenom, Inc. · First submitted before Sequenom, Inc. became part of Labcorp

• Non-Invasive Screening for Fetal AneuploidyCompletedNCT00847990

  Sponsor listed in the registry: Sequenom, Inc. · First submitted before Sequenom, Inc. became part of Labcorp

• Evaluation of Fetal Sex in Assisted Reproductive Technology (ART) Achieved PregnanciesCompletedNCT01021085

  Sponsor listed in the registry: Sequenom, Inc. · First submitted before Sequenom, Inc. became part of Labcorp

• Development of a Fetal Sex Assay From Maternal Whole BloodCompletedNCT00970047

  Sponsor listed in the registry: Sequenom, Inc. · First submitted before Sequenom, Inc. became part of Labcorp

• Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma MarkerCompletedNCT00770458

  Sponsor listed in the registry: Sequenom, Inc. · First submitted before Sequenom, Inc. became part of Labcorp